drugset / Trial / NCT00002936

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer

NCT00002936

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of altretamine plus etoposide in treating patients with HIV-related cancer.

Timeline

Start
1996-07
Primary completion
2007-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoposide Small molecule
Subject altretamine Small molecule

Indications